Literature DB >> 7608966

NMR structure of a stable "OB-fold" sub-domain isolated from staphylococcal nuclease.

A T Alexandrescu1, A G Gittis, C Abeygunawardana, D Shortle.   

Abstract

Similar folds often occur in proteins with dissimilar sequences. The OB-fold forms a part of the structures of at least seven non-homologous proteins that share either oligonucleotide or oligosaccharide binding functions. A 1-103 fragment corresponding to the OB-fold of the 149 amino acid residue staphylococcal nuclease gives NMR spectra characteristic of an unfolded protein, i.e. the wild-type nuclease sequence is insufficient to maintain a stable tertiary structure in the absence of the C-terminal one-third of this single-domain protein. By contrast, the 1-103 fragment of nuclease with the mutations Val66Leu and Gly88Val adopts a stable tertiary structure. The NMR solution structure of this latter fragment is a close variation of the OB-fold found in the X-ray structure of the parent protein. The Val66Leu and Gly88Val mutations appear to stabilize tertiary structure by consolidating the hydrophobic core of the nuclease OB-fold sub-domain. Taken together, these results suggest that recurrent structural motifs such as the OB-fold may in some cases represent vestiges of autonomous folding units that, during evolution, have become integrated into more complex cooperative folding domains.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7608966     DOI: 10.1006/jmbi.1995.0365

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  15 in total

1.  Early formation of a beta hairpin during folding of staphylococcal nuclease H124L as detected by pulsed hydrogen exchange.

Authors:  William F Walkenhorst; Jason A Edwards; John L Markley; Heinrich Roder
Journal:  Protein Sci       Date:  2002-01       Impact factor: 6.725

2.  Cavities determine the pressure unfolding of proteins.

Authors:  Julien Roche; Jose A Caro; Douglas R Norberto; Philippe Barthe; Christian Roumestand; Jamie L Schlessman; Angel E Garcia; Bertrand E García-Moreno; Catherine A Royer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-10       Impact factor: 11.205

Review 3.  Protein folding for realists: a timeless phenomenon.

Authors:  D Shortle; Y Wang; J R Gillespie; J O Wrabl
Journal:  Protein Sci       Date:  1996-06       Impact factor: 6.725

4.  The human EBNA-2 coactivator p100: multidomain organization and relationship to the staphylococcal nuclease fold and to the tudor protein involved in Drosophila melanogaster development.

Authors:  I Callebaut; J P Mornon
Journal:  Biochem J       Date:  1997-01-01       Impact factor: 3.857

5.  P100, a transcriptional coactivator, is a human homologue of staphylococcal nuclease.

Authors:  C P Ponting
Journal:  Protein Sci       Date:  1997-02       Impact factor: 6.725

6.  An engineered amino-terminal domain of yeast phosphoglycerate kinase with native-like structure.

Authors:  M A Sherman; Y Chen; M T Mas
Journal:  Protein Sci       Date:  1997-04       Impact factor: 6.725

7.  Folding stability and cooperativity of the three forms of 1-110 residues fragment of staphylococcal nuclease.

Authors:  Tao Xie; Dongsheng Liu; Yingang Feng; Lu Shan; Jinfeng Wang
Journal:  Biophys J       Date:  2006-12-15       Impact factor: 4.033

8.  A fragment of staphylococcal nuclease with an OB-fold structure shows hydrogen-exchange protection factors in the range reported for "molten globules".

Authors:  A T Alexandrescu; S A Dames; R Wiltscheck
Journal:  Protein Sci       Date:  1996-09       Impact factor: 6.725

9.  Structural insights on the Mycobacterium tuberculosis proteasomal ATPase Mpa.

Authors:  Tao Wang; Hua Li; Gang Lin; Chunyan Tang; Dongyang Li; Carl Nathan; K Heran Darwin; Huilin Li
Journal:  Structure       Date:  2009-10-14       Impact factor: 5.006

10.  Relative stabilities of conserved and non-conserved structures in the OB-fold superfamily.

Authors:  Kaitlyn M Guardino; Sarah R Sheftic; Robert E Slattery; Andrei T Alexandrescu
Journal:  Int J Mol Sci       Date:  2009-05-22       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.